Floatz logo

Tirzepatide

Type 1 Diabetes Mellitus

Royal North Shore Hospitalprotein_peptidePhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Type 1 Diabetes Mellitus cohort.

Asset / SponsorPhaseRating
Metformin
Heba M. Ismail
Phase 4A
Liraglutide
Dasman Diabetes Institute
Phase 4BBB
Semaglutide
Nordsjaellands Hospital
Phase 3BB
ct-868
Carmot Therapeutics, Inc.
Phase 2BB
Glucagon
Charite University, Berlin, Germany
Phase 3B

View all 21 →

Same molecule, other indications

Tirzepatide is also rated in:

diastolic heart failureActive
BBB
Indicative · Phase 4
74 / 100
View asset →
psoriatic arthritisActive
BBB
Indicative · Phase 4
74 / 100
View asset →
metabolic diseaseActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →